
Sign up to save your podcasts
Or


In this episode, Dr. Brandon and Dr. Morgentaler talk about the long-standing belief that testosterone therapy increases the risk of prostate cancer, a fear that has influenced medical guidelines and practice for decades. 2:23 - Charles Huggins and Prostate Cancer Theory: Dr. Morgentaler discusses Charles Huggins' Nobel-winning research that suggested testosterone could fuel prostate cancer growth. 19:56 - Impact of Low Testosterone on Quality of Life: Many men with low testosterone experience significant issues with energy, mood, and s*xual health. 29:17 - The 94-Year-Old Patient's Influence: A 94-year-old patient's decision to try testosterone therapy led Dr. Morgentaler to rethink the risks traditionally associated with treatment. 33:16 - The TRAVERSE Trial's Findings: This pivotal study demonstrated no increased prostate cancer risk among men receiving testosterone therapy compared to those who did not. 39:13 - Why Women Don't Get Prostate Cancer: Despite having analogous glandular tissue, women rarely develop prostate cancer, a topic Dr. Morgentaler examines. Resources: Huggins, C. (1941). Studies on prostatic cancer: The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293-297. https://doi.org/10.1158/ajc.1941.293 Morgentaler, A., Bruning, E. O., & DeWolf, W. C. (1996). Occult prostate cancer in men with low serum testosterone levels. Journal of the American Medical Association, 275(24), 1904-1906. https://doi.org/10.1001/jama.1996.03530480058034 Glaser, R., & Dimitrakakis, C. (2004). Reduced breast cancer incidence in women treated with subcutaneous testosterone implants. Maturitas, 49(4), 333-338. https://doi.org/10.1016/j.maturitas.2004.04.011 Lincoff, A. M., Harman, S. M., Mora, S., Bhatt, D. L., Carson, C., Cejka, M., ... & TRAVERSE Investigators. (2023). Cardiovascular and other long-term outcomes with testosterone use in men. New England Journal of Medicine, 388(6), 495–505. https://doi.org/10.1056/NEJMoa2215025 #ProstateCancer #TestosteroneTherapy #MedicalBeliefs
With Dr. Abraham Morgentaler and Dr. Marianne Brandon Listen to the podcast on all of your favorite platforms: Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7 Find us on: Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== Facebook: https://www.facebook.com/thesexdoctors YouTube: https://www.youtube.com/@thesexdoctorspod TikTok: https://www.tiktok.com/@thesexdoctor LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6 LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513 X (Dr. Abraham): https://x.com/DrMorgentaler X (Dr. Marianne): https://x.com/drbrandon
By Dr. Marianne Brandon and Dr. Abe Morgentaler5
77 ratings
In this episode, Dr. Brandon and Dr. Morgentaler talk about the long-standing belief that testosterone therapy increases the risk of prostate cancer, a fear that has influenced medical guidelines and practice for decades. 2:23 - Charles Huggins and Prostate Cancer Theory: Dr. Morgentaler discusses Charles Huggins' Nobel-winning research that suggested testosterone could fuel prostate cancer growth. 19:56 - Impact of Low Testosterone on Quality of Life: Many men with low testosterone experience significant issues with energy, mood, and s*xual health. 29:17 - The 94-Year-Old Patient's Influence: A 94-year-old patient's decision to try testosterone therapy led Dr. Morgentaler to rethink the risks traditionally associated with treatment. 33:16 - The TRAVERSE Trial's Findings: This pivotal study demonstrated no increased prostate cancer risk among men receiving testosterone therapy compared to those who did not. 39:13 - Why Women Don't Get Prostate Cancer: Despite having analogous glandular tissue, women rarely develop prostate cancer, a topic Dr. Morgentaler examines. Resources: Huggins, C. (1941). Studies on prostatic cancer: The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293-297. https://doi.org/10.1158/ajc.1941.293 Morgentaler, A., Bruning, E. O., & DeWolf, W. C. (1996). Occult prostate cancer in men with low serum testosterone levels. Journal of the American Medical Association, 275(24), 1904-1906. https://doi.org/10.1001/jama.1996.03530480058034 Glaser, R., & Dimitrakakis, C. (2004). Reduced breast cancer incidence in women treated with subcutaneous testosterone implants. Maturitas, 49(4), 333-338. https://doi.org/10.1016/j.maturitas.2004.04.011 Lincoff, A. M., Harman, S. M., Mora, S., Bhatt, D. L., Carson, C., Cejka, M., ... & TRAVERSE Investigators. (2023). Cardiovascular and other long-term outcomes with testosterone use in men. New England Journal of Medicine, 388(6), 495–505. https://doi.org/10.1056/NEJMoa2215025 #ProstateCancer #TestosteroneTherapy #MedicalBeliefs
With Dr. Abraham Morgentaler and Dr. Marianne Brandon Listen to the podcast on all of your favorite platforms: Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7 Find us on: Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== Facebook: https://www.facebook.com/thesexdoctors YouTube: https://www.youtube.com/@thesexdoctorspod TikTok: https://www.tiktok.com/@thesexdoctor LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6 LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513 X (Dr. Abraham): https://x.com/DrMorgentaler X (Dr. Marianne): https://x.com/drbrandon

1,869 Listeners

7,246 Listeners

5,022 Listeners

7,362 Listeners

166 Listeners

3,498 Listeners

9,284 Listeners

216 Listeners

339 Listeners

156 Listeners

616 Listeners

1,073 Listeners

120 Listeners

1,181 Listeners

252 Listeners